PCOR:NYSEProcore Technologies, Inc. Analysis
Data as of 2026-04-23 - not real-time
$53.40
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Procore Technologies (PCOR) is trading at $53.4, which sits below its 20‑day (54.42) and 50‑day (54.96) simple moving averages, signaling a short‑term bearish bias. The stock’s price is hovering above the computed support level of $46.64 but well under the resistance of $59.05, leaving limited upside in the near term. Technical momentum is mixed: the RSI at 46.3 is neutral, while the MACD histogram is positive, giving a bullish signal despite the overall bearish trend.
Fundamentally, the company posted a 15.6% revenue growth year‑over‑year and maintains a strong 79.6% gross margin, yet operating and profit margins remain negative (-11.5% and -7.6% respectively). Cash flow is solid with $300 M operating cash flow and $239 M free cash flow, but the balance sheet shows a high debt‑to‑equity ratio of 6.28, raising leverage concerns. Analysts average a “buy” rating with target prices around $71‑$73, implying roughly a 30% upside, while the DCF‑derived fair value of $44.3 suggests the market is pricing in a premium for expected turnaround.
Fundamentally, the company posted a 15.6% revenue growth year‑over‑year and maintains a strong 79.6% gross margin, yet operating and profit margins remain negative (-11.5% and -7.6% respectively). Cash flow is solid with $300 M operating cash flow and $239 M free cash flow, but the balance sheet shows a high debt‑to‑equity ratio of 6.28, raising leverage concerns. Analysts average a “buy” rating with target prices around $71‑$73, implying roughly a 30% upside, while the DCF‑derived fair value of $44.3 suggests the market is pricing in a premium for expected turnaround.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price below short‑term SMAs indicating bearish bias
- Support level at $46.64 offers downside cushion
- Increasing volume and bullish MACD histogram suggest potential short‑term bounce
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Revenue growth of 15.6% and strong gross margin
- Forward EPS of $2.25 and analyst target median of $73
- Robust operating and free cash flow despite current losses
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Strategic positioning in the growing construction‑software market
- Improving profitability outlook as margins normalize
- High beta (1.38) and volatility (55% 30‑day) imply higher reward for patient investors
Key Metrics & Analysis
Financial Health
Revenue Growth15.60%
Profit Margin-7.62%
P/E Ratio23.7
ROE-7.90%
ROA-3.39%
Debt/Equity6.28
P/B Ratio6.4
Op. Cash Flow$300.3M
Free Cash Flow$239.6M
Industry P/E37.0
Technical Analysis
TrendBearish
RSI46.3
Support$46.64
Resistance$59.05
MA 20$54.42
MA 50$54.96
MA 200$66.59
MACDBullish
VolumeIncreasing
Fear & Greed Index86.95
Valuation
Fair Value$44.32
Target Price$71.00
Upside/Downside32.96%
GradeOvervalued
TypeBlend
Risk Assessment
Beta1.38
Volatility55.12%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.